GDPR and Automated Decision Making in Precision Medicine

The rise of “precision medicine”, the personalization of medical treatments based on large volumes of health data, has led to the increased use of automation. Advancements in data analytics and automated decision-making (ADM) technologies, which analyse vast genomic datasets to pinpoint personalised treatment strategies, have been game changers in the clinical trials space.  Courts [...]

By |2023-10-29T20:45:51+00:0017th October, 2023|DPO, Life Sciences, News|

Data Health checks in healthcare sector

Unlocking the Key to Compliance: Data Privacy Health Checks for Healthcare Organisations  Healthcare companies are some of the biggest targets of cyber-attacks, with health data being a particularly sensitive form of personal data.   Healthcare organisations store, maintain and transmit vast amounts of data to support the delivery of efficient and appropriate patient care. [...]

By |2023-10-20T20:55:44+01:0031st July, 2023|DPO, Governments, International, Life Sciences|

Regulation on Dosimetry and application of administrative Sanctions of the Brazilian General Data Protection Law

Background: The Lei Geral de Proteção de Dados (LGPD) is the Brazilian legal framework that regulates data processing carried out in Brazil and in other countries where the processing operations (i) aim to offer or supply goods and services to people located in Brazil; (ii) process the personal data of people located in Brazil; [...]

By |2023-05-22T12:50:40+01:0022nd May, 2023|DPO, Governments, International, Life Sciences|

Decoding Digital Health: Trans-Atlantic transfers of Health Data

Trans-Atlantic Transfers of Health Data   Since the Covid 19 Pandemic, clinical trials have become more popular across the globe. A potential stumbling block for organisations sponsoring or engaging in clinical trials is trans-Atlantic transfers of health data.   Background  Prior to the Schrems II ruling in 2020, a mechanism to permit the transfer of data [...]

By |2023-05-24T14:25:45+01:0020th May, 2023|DPO, Governments, International, Life Sciences|

The EU AI Framework

Start preparing your business for the EU Framework on artificial intelligence The EU Framework on artificial intelligence (AI), consisting of a regulation establishing harmonised rules on AI (the AI act), and a directive adopting non-contractual civil liability rules to AI (the AI Liability Directive) is expected to be adopted in 2024 or 2025. It [...]

HewardMills Celebrates Ghana Data Protection

We caught up with Senior Health Care Supervisors in Ghana, in conjunction with the Data Protection Commission-Ghana to discuss the current situation on the enforcement mechanisms for regulating personal data within the Health Sector. Every data-driven organisation should have a privacy framework in place. If your organisation hasn’t yet taken the time to orient [...]

By |2023-03-15T12:13:46+00:0013th February, 2023|DPO, Governments, International, Life Sciences|

Clinical trials in Spain: translating the AEPD’s new rules

At one time or another, any organisation with operations in Europe will have had to navigate the GDPR: the European data protection law which sets some of the highest standards for data privacy worldwide. For clinical trial sponsors, there's also the European Clinical Trials Regulation ('CTR') to contend with—alongside international laws governing the life [...]

By |2022-05-27T11:44:50+01:0020th May, 2022|DPO, International, Life Sciences, ThoughtLeadership|

Registering with data protection regulators when sponsoring or conducting clinical trials

Organisations involved in clinical trials in European Union (EU) Member States, or the UK should consider whether they need to register with data protection regulators. Before the General Data Protection Regulation (GDPR) entered into force in May 2018, the data protection laws in the EU (which at the time included the UK) required organisations [...]

By |2024-01-29T12:25:32+00:0026th April, 2022|DPO, Life Sciences|

Top considerations for clinical trials

After the hiatus brought about by the pandemic, activity in the clinical trials sector is now growing, with a number of trials due to launch at the end of this quarter. Increasingly, participants in trials and partners in Clinical Research Organisations (CROs) are seeking assurance that a Data Protection Officer (DPO) has been appointed [...]

By |2022-03-31T09:34:17+01:0026th January, 2022|DPO, Life Sciences, News, ThoughtLeadership|
Go to Top